Number of Suspected 'Room Temperature Exposure' Flu Vaccine Recipients Slightly Reduced to 2,295... Data Correction

8 People Decrease Ahead of Announcement on 3rd... Some Corrections by Local Governments
Vaccination Plan Expected to Be Announced as Early as 6th or 7th

[Image source=Yonhap News]

[Asia Economy Reporter Lim Cheol-young] The number of people vaccinated with the flu vaccine, which was suspected of 'room temperature exposure' during the distribution process and had its administration suspended, has decreased to 2,295, down from the previous figure.

On the 4th, the Korea Disease Control and Prevention Agency (KDCA) announced through reference materials related to the suspension of the national flu vaccine expected vaccination project that the number of government-procured vaccine doses administered under investigation was 2,295 as of the 3rd. This is a correction reflecting a decrease of 8 from the previous 2,303.

The KDCA explained the decrease in numbers by stating, "Some figures were corrected by local governments, resulting in the decrease."

Vaccinations were confirmed in 15 metropolitan cities and provinces. Gyeonggi had the highest number with 673 cases, followed by Gwangju (361), Jeonbuk (326), Incheon (214), Gyeongbuk (161), Seoul (149), Daegu (105), Busan (101), Chungnam (74), Sejong (51), Jeonnam (40), Daejeon (17), Gyeongnam (14), Jeju (8), and Chungbuk (1).

The timing of vaccinations showed that before the 21st of last month, 1,599 people were vaccinated at 142 medical institutions, accounting for 67.9%. On the 22nd, when the suspension of vaccine administration was announced, 458 doses were administered at 124 institutions, representing 19.9%, and after the 23rd, 238 people were vaccinated at 34 institutions.

Earlier, the KDCA confirmed that 'Shinseong Yakpum,' the supplier of the national procurement vaccine, did not adhere to the cold chain principles during the delivery process and announced the suspension of the project on the 21st of last month. Approximately 5.78 million doses of vaccine suspected of room temperature exposure were suspended from use.

The number of vaccinated individuals increased from zero on the 22nd, when the KDCA announced the suspension of vaccine use, to 105 → 224 → 324 → 407 → 873 → 1,362 → 1,910 → 2,290 → 2,303 after the 25th.

The KDCA plans to set a schedule for resuming vaccinations after the quality inspection results conducted by the Ministry of Food and Drug Safety are released. The inspection results are expected as early as the 6th or 7th.

This content was produced with the assistance of AI translation services.